Literature DB >> 8358302

Fibronectin type III modules in the receptor phosphatase CD45 and tapeworm antigens.

P Bork1, R F Doolittle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358302      PMCID: PMC2142425          DOI: 10.1002/pro.5560020714

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


× No keyword cloud information.
  14 in total

1.  A family of receptor-linked protein tyrosine phosphatases in humans and Drosophila.

Authors:  M Streuli; N X Krueger; A Y Tsai; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  A human transmembrane protein-tyrosine-phosphatase, PTP zeta, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases.

Authors:  N X Krueger; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 3.  Stein and Moore Award address. Reconstructing history with amino acid sequences.

Authors:  R F Doolittle
Journal:  Protein Sci       Date:  1992-02       Impact factor: 6.725

4.  Proposed acquisition of an animal protein domain by bacteria.

Authors:  P Bork; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

5.  The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions.

Authors:  A L Main; T S Harvey; M Baron; J Boyd; I D Campbell
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

6.  Database of homology-derived protein structures and the structural meaning of sequence alignment.

Authors:  C Sander; R Schneider
Journal:  Proteins       Date:  1991

7.  Molecular cloning of Taenia taeniaeformis oncosphere antigen genes.

Authors:  W G Cougle; M W Lightowlers; H O Bogh; M D Rickard; K S Johnson
Journal:  Mol Biochem Parasitol       Date:  1991-03       Impact factor: 1.759

8.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

9.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

10.  Vaccination against ovine cysticercosis using a defined recombinant antigen.

Authors:  K S Johnson; G B Harrison; M W Lightowlers; K L O'Hoy; W G Cougle; R P Dempster; S B Lawrence; J G Vinton; D D Heath; M D Rickard
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

View more
  6 in total

1.  Crystal structure of a heparin- and integrin-binding segment of human fibronectin.

Authors:  A Sharma; J A Askari; M J Humphries; E Y Jones; D I Stuart
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Analysis of cDNAs coding for immunologically dominant antigens from an oncosphere-specific cDNA library of Echinococcus multilocularis.

Authors:  Armin Merckelbach; Martina Wager; Richard Lucius
Journal:  Parasitol Res       Date:  2003-06-26       Impact factor: 2.289

3.  Organization, alternative splicing, polymorphism, and phylogenetic position of lamprey CD45 gene.

Authors:  Tatiana Uinuk-Ool; Nikolas Nikolaidis; Akie Sato; Werner E Mayer; Jan Klein
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

4.  A quantitative methodology for the de novo design of proteins.

Authors:  S E Brenner; A Berry
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

5.  The tyrosine corner: a feature of most Greek key beta-barrel proteins.

Authors:  J M Hemmingsen; K M Gernert; J S Richardson; D C Richardson
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

6.  Evaluation of Immunogenicity of Novel Isoform of EG95 (EG95-5G1) From Echinococcus granulosus in BALB/C Mice.

Authors:  Majid Pirestani; Abdolhossein Dalimi; Shahabodin Sarvi; Nima Khoramabadi
Journal:  Iran J Parasitol       Date:  2014 Oct-Dec       Impact factor: 1.012

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.